Eran Broshy sold Theravance Biopharma ($TBPH) shares on the open market eight times over the past year, totaling $2.5 million. His most recent sale occurred on November 26, 2025. Among nearly 12,000 individual insiders with open market sales, Broshy's activity ranks 3,076th by value, below the average of $8.6 million across 6.4 transactions per person. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 26, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 14000 | $20.00 | 60,204.0000 | 51,908,000 | 18.87% | 0.03% |
| Nov. 26, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | M | Share Option (Right to Buy) | 14000 | $10.15 | 81,749.0000 | 51,908,000 | 20.66% | 0.03% |
| Nov. 26, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 15501 | $20.00 | 44,703.0000 | 51,908,000 | 25.75% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 15500 | $18.50 | 75,704.0000 | 51,908,000 | 16.99% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | M | Share Option (Right to Buy) | 14000 | $10.15 | 107,878.0000 | 51,908,000 | 14.91% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 14000 | $18.50 | 60,204.0000 | 51,908,000 | 18.87% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 15500 | $17.00 | 60,204.0000 | 51,908,000 | 20.47% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | M | Share Option (Right to Buy) | 14000 | $10.15 | 107,878.0000 | 51,908,000 | 14.91% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 29500 | $18.50 | 61,704.0000 | 51,908,000 | 32.35% | 0.06% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 15500 | $17.00 | 46,204.0000 | 51,908,000 | 25.12% | 0.03% |
| Nov. 11, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | S | Ordinary Shares | 14000 | $18.50 | 46,204.0000 | 51,908,000 | 23.25% | 0.03% |
| May 21, 2025 | Certara, Inc. | $CERT | BROSHY ERAN | Not found | M | Restricted Stock Units | 11928 | $0.00 | 0.0000 | 161,958,810 | 100.00% | 0.01% |
| May 21, 2025 | Certara, Inc. | $CERT | BROSHY ERAN | Not found | M | Common Stock | 11928 | $0.00 | 34,951.0000 | 161,958,810 | 51.81% | 0.01% |
| May 21, 2025 | Certara, Inc. | $CERT | BROSHY ERAN | Not found | A | Restricted Stock Units | 15757 | $0.00 | 15,757.0000 | 161,958,810 | 9999.99% | 0.01% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | A | Ordinary Shares | 10649 | $0.00 | 91,204.0000 | 49,706,000 | 13.22% | 0.02% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | A | Share Option (Right to Buy) | 24258 | $0.00 | 24,258.0000 | 49,706,000 | 9999.99% | 0.05% |
| May 21, 2024 | Certara, Inc. | $CERT | BROSHY ERAN | Not found | M | Restricted Stock Units | 8663 | $0.00 | 0.0000 | 160,284,901 | 100.00% | 0.01% |
| May 21, 2024 | Certara, Inc. | $CERT | BROSHY ERAN | Not found | M | Common Stock | 8663 | $0.00 | 23,023.0000 | 160,284,901 | 60.33% | 0.01% |
| May 21, 2024 | Certara, Inc. | $CERT | BROSHY ERAN | Not found | A | Restricted Stock Units | 11928 | $0.00 | 11,928.0000 | 160,284,901 | 9999.99% | 0.01% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | A | Share Option (Right to Buy) | 23576 | $0.00 | 23,576.0000 | 48,283,000 | 9999.99% | 0.05% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | BROSHY ERAN | Not found | A | Ordinary Shares | 10537 | $0.00 | 80,555.0000 | 48,283,000 | 15.05% | 0.02% |